Rhonda Farrell

Also affiliated with UNSW Sydney, Chris O’Brien Lifehouse, Prince of Wales Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study”.

CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Cancer(2022)10.1002/cncr.34582

N/A

1.2DataRank · unranked

46 citations

Ashley Weir, Nicola S. Meagher, Kyo Farrington, Gregg Nelson, Prafull Ghatage +95 more

Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac160

N/A

0.513DataRank · unranked

13 citations

Joe Dennis, Jonathan P. Tyrer, Pei-Chen Peng, Simon G. Coetzee, Alberto Luiz P. Reyes +94 more

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1206

N/A

0.464DataRank · unranked

21 citations

Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S. Chiu +95 more

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2021)10.1007/s00428-021-03232-0

N/A

0DataRank · unranked

23 citations

Joshua Millstein, Gordana Popović, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk +95 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma

medRxiv(2025)10.1101/2025.09.17.25335919

N/A

0DataRank · unranked

0 citations

Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey +95 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Research Square(2025)10.21203/rs.3.rs-7572112/v1

N/A

0DataRank · unranked

0 citations

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana +95 more